Inhibition of Pseudomonas aeruginosa with a recombinant RNA-based viral vector expressing human β-defensin 4

NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults

(2012) Clint S. Schmidt et al.   VACCINE

Effective Method to Remove Wound Bacteria: Comparison of Various Debridement Modalities in an In Vivo Porcine Model

(2011) Aron G. Nusbaum et al.   JOURNAL OF SURGICAL RESEARCH

Introduction of human β-defensin-3 into cultured human keratinocytes and fibroblasts by infection of a recombinant adenovirus vector

(2010) Yosuke Suzuki et al.   BURNS

Infection control in the burn unit

(2010) Karim Rafla et al.   BURNS

Antibiotic resistance in clinical isolates of Acinetobacter baumannii, Pseudomonas aeruginosa, and Staphylococcus aureus does not impact sensitivity to human beta defensin 4

(2009) Dorothy M. Supp et al.   BURNS

Changes in bacterial isolates from burn wounds and their antibiograms: A 20-year study (1986–2005)

(2009) Merlin Guggenheim et al.   BURNS

Genetically engineered Newcastle disease virus for malignant melanoma therapy

(2009) D Zamarin et al.   GENE THERAPY

Burn Injuries

(2009) Janet M. Torpy   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Expression of Transgenes from Newcastle Disease Virus with a Segmented Genome

(2008) Q. Gao et al.   JOURNAL OF VIROLOGY

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis

(2008) M Juliana McElrath et al.   LANCET